GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-2 reverse transcriptase

Analyse Crystal structure of HIV-2 reverse transcriptase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MU2
Type
protein
Length
940 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-2 rt
EC
2.7.7.49
UniProt
P04584
Ligands
SO4
Pockets
16 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-2 rt (EC 2.7.7.49)protein53833% helix, 25% strandP04584
BHIV-2 rt (EC 2.7.7.49)protein40238% helix, 20% strandP04584

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 22 copies · chains A, B
  • GOL · Glycerol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16350.720.7972empty
26290.700.7860GOL
32990.680.8332GOL
43320.660.8132SO4, GOL
5990.650.9028SO4

Interfaces

1 interface between chains.

  • A–B · 3063 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 1MU2 · Crystal structure of HIV-2 reverse transcriptase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.